Sdelci, Sara
Rendeiro, André F. http://orcid.org/0000-0001-9362-5373
Rathert, Philipp
You, Wanhui
Lin, Jung-Ming G.
Ringler, Anna
Hofstätter, Gerald
Moll, Herwig P. http://orcid.org/0000-0001-6438-9068
Gürtl, Bettina
Farlik, Matthias http://orcid.org/0000-0003-0698-2992
Schick, Sandra http://orcid.org/0000-0002-4061-2381
Klepsch, Freya
Oldach, Matthew
Buphamalai, Pisanu
Schischlik, Fiorella http://orcid.org/0000-0003-4299-7657
Májek, Peter
Parapatics, Katja
Schmidl, Christian http://orcid.org/0000-0002-0522-202X
Schuster, Michael http://orcid.org/0000-0003-2975-8969
Penz, Thomas
Buckley, Dennis L.
Hudecz, Otto
Imre, Richard
Wang, Shuang-Yan
Maric, Hans Michael http://orcid.org/0000-0002-2719-4752
Kralovics, Robert
Bennett, Keiryn L. http://orcid.org/0000-0001-9356-7708
Müller, Andre C.
Mechtler, Karl
Menche, Jörg http://orcid.org/0000-0002-1583-6404
Bradner, James E. http://orcid.org/0000-0002-2718-4415
Winter, Georg E.
Klavins, Kristaps
Casanova, Emilio http://orcid.org/0000-0001-7992-5361
Bock, Christoph http://orcid.org/0000-0001-6091-3088
Zuber, Johannes http://orcid.org/0000-0001-8810-6835
Kubicek, Stefan http://orcid.org/0000-0003-0855-8343
Article History
Received: 18 April 2018
Accepted: 4 April 2019
First Online: 27 May 2019
Competing interests
: S. Sdelci and S.K. have filed patent application WO/2018/087401 based on the findings described in this manuscript. J.E.B. is now a shareholder and executive of Novartis AG, and was formerly the founder of the BET bromodomain-focused company Tensha (acquired by Roche).